相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumors
Hao-Yue Xiang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells
Yu-xiang Wang et al.
CELL DEATH & DISEASE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Advances and challenges in the treatment of esophageal cancer
Shiming He et al.
ACTA PHARMACEUTICA SINICA B (2021)
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma
Manish A. Shah et al.
FUTURE ONCOLOGY (2021)
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Jeroen M. Bugter et al.
NATURE REVIEWS CANCER (2021)
HER2-targeted therapies - a role beyond breast cancer
Do-Youn Oh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma
Simon Schallenberg et al.
BMC CANCER (2020)
z Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
Charlotte Stroes et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors
John H. Strickler et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging
D. J. J. M. de Gouw et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
Ahlem Essakly et al.
TRANSLATIONAL ONCOLOGY (2020)
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Yongping Cui et al.
CELL RESEARCH (2020)
Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma
Shinya Ohashi et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
Minran Huang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study
Li Yanwei et al.
ONCOLOGIST (2020)
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial
Congying Xie et al.
BRITISH JOURNAL OF CANCER (2020)
Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma A Phase II Randomized Clinical Trial
Honglei Luo et al.
JAMA NETWORK OPEN (2020)
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma
Bo Zhang et al.
CANCER COMMUNICATIONS (2020)
Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
Yanqiu Wang et al.
BMC CANCER (2019)
Targeting the untargetable KRAS in cancer therapy
Pingyu Liu et al.
ACTA PHARMACEUTICA SINICA B (2019)
COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer
Richard J. Fagan et al.
CANCER LETTERS (2019)
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody
Xi Wang et al.
THORACIC CANCER (2019)
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial
Elizabeth C. Smyth et al.
JAMA ONCOLOGY (2019)
PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment
Jia-jie Shi et al.
CANCER LETTERS (2019)
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma
Dan Su et al.
NATURE COMMUNICATIONS (2019)
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
Patrick Sven Plum et al.
BMC CANCER (2019)
AMulticenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors
Eric Van Cutsem et al.
CLINICAL CANCER RESEARCH (2019)
Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors
David S. Hong et al.
CLINICAL CANCER RESEARCH (2019)
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus The Phase 2 KEYNOTE-180 Study
Manish A. Shah et al.
JAMA ONCOLOGY (2019)
Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target
Shaohua Ma et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma
Matthew D. Stachler et al.
GASTROENTEROLOGY (2018)
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma
Mohamed E. Salem et al.
ONCOLOGIST (2018)
Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma
Yuanyuan Zhao et al.
CELL DEATH & DISEASE (2018)
Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma
Nan Kang et al.
BMC CELL BIOLOGY (2018)
Loss of Notch1 predisposes oro-esophageal epithelium to tumorigenesis
Wanlada Sawangarun et al.
EXPERIMENTAL CELL RESEARCH (2018)
A catalogue of somatic NRF2 gain-of-function mutations in cancer
Michael John Kerins et al.
SCIENTIFIC REPORTS (2018)
Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma
Zhongwei Xin et al.
THORACIC CANCER (2018)
A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification
Hanting Zhu et al.
JOURNAL OF THORACIC DISEASE (2018)
A Next-Generation Sequencing PrimerHow Does It Work and What Can It Do?
Yuriy O. Alekseyev et al.
ACADEMIC PATHOLOGY (2018)
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
Bryan J. Schneider et al.
CLINICAL CANCER RESEARCH (2017)
WNT SIGNALING PROTEIN EXPRESSION BASED PRIDICTION OF RECURRENT FREE SURVIVAL IN ESOPHAGEAL CANCER
Mohd R. Hasan et al.
GASTROENTEROLOGY (2017)
Histone H3 lysine 4 methyltransferase KMT2D
Eugene Froimchuk et al.
GENE (2017)
Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma
Wei Dai et al.
JOURNAL OF PATHOLOGY (2017)
Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma
Dong Wang et al.
ONCOTARGET (2017)
High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
Qi Song et al.
ONCOTARGET (2017)
CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease
Juliann E. Kosovec et al.
ONCOTARGET (2017)
Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
Amedeo Carraro et al.
CANCER SCIENCE (2017)
International cancer seminars: a focus on esophageal squamous cell carcinoma
G. Murphy et al.
ANNALS OF ONCOLOGY (2017)
Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas
Michael G. Drage et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population
Xiaoming Lin et al.
CANCER SCIENCE (2017)
Role of fibroblast growth factor receptors in esophageal squamous cell carcinoma
Yutaka Shimada et al.
ESOPHAGUS (2016)
Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China
Bin Song et al.
ONCOTARGET (2016)
Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
Caixia Cheng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold
Zhixiang Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population
Genta Sawada et al.
GASTROENTEROLOGY (2016)
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
Suzanne Leijen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study
Jing Huang et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Identification of candidate target genes of genomic aberrations in esophageal squamous cell carcinoma
Tian-Yun Shen et al.
ONCOLOGY LETTERS (2016)
A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
Chuanhua Zhao et al.
ONCOTARGET (2016)
Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma
Xue Hou et al.
ONCOTARGET (2016)
PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
Hyo Song Kim et al.
ONCOTARGET (2016)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: Controversies and Perspectives
Lixia Guo et al.
DISEASE MARKERS (2015)
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine
Theresa D. Ahrens et al.
EPIGENETICS (2015)
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Joel H. Rubenstein et al.
GASTROENTEROLOGY (2015)
Paired exome analysis of Barrett's esophagus and adenocarcinoma
Matthew D. Stachler et al.
NATURE GENETICS (2015)
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences
Kai Wang et al.
ONCOLOGIST (2015)
Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study
Yaping Xu et al.
ONCOTARGET (2015)
In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma
S. Realdon et al.
DISEASES OF THE ESOPHAGUS (2015)
Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma
Wencheng Zhang et al.
ANNALS OF THORACIC SURGERY (2014)
HER-2/neu Gene Amplification in Relation to Expression of HER2 and HER3 Proteins in Patients With Esophageal Adenocarcinoma
Harry H. Yoon et al.
CANCER (2014)
The emerging roles of ARID1A in tumor suppression
Ren-Chin Wu et al.
CANCER BIOLOGY & THERAPY (2014)
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Bernard Leroy et al.
HUMAN MUTATION (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Genetic landscape of esophageal squamous cell carcinoma
Yi-Bo Gao et al.
NATURE GENETICS (2014)
Genomic and molecular characterization of esophageal squamous cell carcinoma
De-Chen Lin et al.
NATURE GENETICS (2014)
Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus
M. M. Streppel et al.
ONCOGENE (2014)
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
Katia Nones et al.
NATURE COMMUNICATIONS (2014)
Common genetic variants in the 9p21 region and their associations with multiple tumours
F. Gu et al.
BRITISH JOURNAL OF CANCER (2013)
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
Hiroaki Kato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models
Wenmin Hou et al.
ONCOLOGY REPORTS (2013)
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
Bryant England et al.
TUMOR BIOLOGY (2013)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
A. Nigel Brooks et al.
CLINICAL CANCER RESEARCH (2012)
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
Harry H. Yoon et al.
CLINICAL CANCER RESEARCH (2012)
Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma
M. J. D. Prins et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
Lei Zhao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines
Kousaku Mimura et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
Jochen K. Lennerz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma
Wei Wang et al.
MEDICAL ONCOLOGY (2011)
NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer
Tatsuhiro Shibata et al.
NEOPLASIA (2011)
PHASE II STUDY OF CONCURRENT CHEMORADIATION IN COMBINATION WITH ERLOTINIB FOR LOCALLY ADVANCED ESOPHAGEAL CARCINOMA
Gang Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Clinical Relevance of KRAS in Human Cancers
Sylwia Jancik et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
Yoo Ri Kim et al.
JOURNAL OF PATHOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion
Katharine D. Grugan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma
Ichiro Akagi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Epigenetic Silencing of the p16INK4a Tumor Suppressor Is Associated with Loss of CTCF Binding and a Chromatin Boundary
Michael Witcher et al.
MOLECULAR CELL (2009)
Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues
Jing Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
E. A. Griffiths et al.
BRITISH JOURNAL OF CANCER (2007)
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression
Burkhard H. A. von Rahden et al.
NEOPLASIA (2006)
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus
M Hanawa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo
F Hara et al.
CANCER LETTERS (2005)
ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma
F Teralshi et al.
FEBS LETTERS (2005)
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
J Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma
P Sunpaweravong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma
LJ Herrera et al.
NEOPLASIA (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Review of epidermal growth factor receptor biology
RS Herbst
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis
H Arai et al.
CANCER GENETICS AND CYTOGENETICS (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus:: the CDKN2A (p16INK4a and p14ARF) and p53 genes are major targets for inactivation
J Smeds et al.
CARCINOGENESIS (2002)
p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus
YS Bian et al.
GASTROENTEROLOGY (2002)
分享论文
